Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Petition Answers FDA Questions On Oral Phenylephrine Efficacy, Suggests Removal From Monograph

This article was originally published in The Tan Sheet

Executive Summary

A citizen petition says studies have answered the question FDA and advisory committee members asked in 2007, for studies on the most effective dose of PE as a nasal decongestant. The studies show “PE is no more effective than placebo,” the petition says.


Related Content

FDA Status Updates On Citizen Petitions Would Not Signal Decision Pending
Study Stirs Doubts On Phenylephrine, Questions On Monograph Process
Data Support Phenylephrine Efficacy, But More Studies Needed – NDAC
Citizen Petition On Phenylephrine Requests Pulling OTC Status For Children





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts